MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 16.03.2026
Cue Biopharma Kurshistorie 2011-2026 | CUE
Kurshistorie Jährlich Cue Biopharma
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.31 | 0.91 | 1.89 | 3.04 | 11.3 | 12.5 | 15.9 | 4.7 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 15.9 | 0.31 | 6.32 |
Kurshistorie anderer Aktien in der Pharmaeinzelhändler
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M |  Germany |
 |
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M |  USA |
 |
Takeda Pharmaceutical Company Limited
TAK
|
13.6 | $ 18.06 | - | $ 28.2 B |  Japan |
 |
Amphastar Pharmaceuticals
AMPH
|
26.7 | $ 19.44 | -0.46 % | $ 909 M | USA |
 |
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M |  Canada |
 |
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | USA |
 |
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | USA |
 |
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | USA |
 |
I-Mab
IMAB
|
0.68 | - | - | $ 866 M |  China |
 |
Genfit SA
GNFT
|
3.36 | - | 2.54 % | $ 160 B |  France |
 |
Albireo Pharma
ALBO
|
28.5 | - | -0.23 % | $ 916 M | USA |
 |
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M | France |
 |
Aileron Therapeutics
ALRN
|
2.13 | - | 10.36 % | $ 9.8 M | USA |
 |
Aptinyx
APTX
|
0.14 | - | -39.0 % | $ 4.57 M | USA |
 |
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Arena Pharmaceuticals
ARNA
|
92.9 | - | -6.81 % | $ 3.04 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.3 | - | - | $ 26.5 M | USA |
 |
Avenue Therapeutics
ATXI
|
0.42 | - | -52.27 % | $ 4.45 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M |  Israel |
 |
Atreca
BCEL
|
1.27 | - | -11.76 % | $ 5.79 M | USA |
 |
Protara Therapeutics
TARA
|
5.71 | $ 5.03 | -3.08 % | $ 215 M | USA |
 |
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | USA |
 |
Tarsus Pharmaceuticals
TARS
|
69.9 | $ 67.0 | -0.3 % | $ 2.8 B | USA |
 |
bluebird bio
BLUE
|
0.61 | - | - | $ 546 M | USA |
 |
Acasti Pharma
ACST
|
3.37 | - | 4.01 % | $ 150 M | Canada |
 |
Theravance Biopharma
TBPH
|
14.8 | $ 14.9 | -1.91 % | $ 750 M |  Cayman-islands |
 |
Avid Bioservices
CDMO
|
6.7 | - | - | $ 789 M | USA |
 |
Adverum Biotechnologies
ADVM
|
3.86 | - | - | $ 86.2 M | USA |
 |
Acer Therapeutics
ACER
|
0.77 | - | 2.71 % | $ 14 M | USA |
 |
Advaxis
ADXS
|
0.31 | - | -9.65 % | $ 45.9 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
1.66 | $ 1.2 | -6.97 % | $ 306 M | Britain |
 |
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B | Cayman-islands |
 |
Bio-Techne Corporation
TECH
|
57.1 | $ 51.31 | -2.65 % | $ 8.08 B | USA |
 |
Tenax Therapeutics
TENX
|
14.5 | $ 14.64 | -2.2 % | $ 574 M | USA |
 |
BioDelivery Sciences International
BDSI
|
3.1 | - | -4.8 % | $ 255 M | USA |
 |
Cara Therapeutics
CARA
|
1 | - | -3.03 % | $ 260 M | USA |
 |
ChemoCentryx
CCXI
|
26.9 | - | - | $ 3.74 B | USA |
|
Enlivex Therapeutics Ltd.
ENLV
|
0.89 | $ 1.07 | -2.29 % | $ 21.9 M | Israel |
 |
Teva Pharmaceutical Industries Limited
TEVA
|
36.1 | $ 28.76 | -3.43 % | $ 32.9 B | Israel |
 |
Enochian Biosciences
ENOB
|
0.7 | - | - | $ 40.5 M | USA |
 |
CureVac N.V.
CVAC
|
19.3 | - | - | $ 867 M | Germany |
 |
Equillium
EQ
|
2.06 | $ 2.03 | -1.46 % | $ 116 M | USA |
 |
Eton Pharmaceuticals
ETON
|
20.8 | $ 23.81 | 1.51 % | $ 641 M | USA |
 |
Bellerophon Therapeutics
BLPH
|
8.23 | - | -74.18 % | $ 955 K | USA |
 |
CRISPR Therapeutics AG
CRSP
|
48.8 | $ 46.38 | -2.45 % | $ 4.17 B |  Schweiz |